Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.
- DOI
- 10.1021/acs.jmedchem.4c02225
- Published
- 2025 Feb 13
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.4c02225,
title = {Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.},
author = {Dutheuil G and Oukoloff K and Korac J and Lenoir F and El Bousmaqui M and Probst N and Lapin A and Nakhabina G and Sorlet C and Parmentier N and Karila D and Ghavtadze N and Casault P and Claridge S and Sapmaz S and Slater MJ and Fraser GL},
year = {2025},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.4c02225},
url = {https://doi.org/10.1021/acs.jmedchem.4c02225}
}RIS
TY - JOUR TI - Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models. AU - Dutheuil G AU - Oukoloff K AU - Korac J AU - Lenoir F AU - El Bousmaqui M AU - Probst N AU - Lapin A AU - Nakhabina G AU - Sorlet C AU - Parmentier N AU - Karila D AU - Ghavtadze N AU - Casault P AU - Claridge S AU - Sapmaz S AU - Slater MJ AU - Fraser GL PY - 2025 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.4c02225 UR - https://doi.org/10.1021/acs.jmedchem.4c02225 ER -
APA
G, D., K, O., J, K., F, L., M, E. B., N, P., A, L., G, N., C, S., N, P., D, K., N, G., P, C., S, C., S, S., MJ, S., & GL, F. (2025). Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.4c02225
Source records
- pubmed · retrieved 2026-09-27T16:00:10.278Z